Targeting host cells harbouring viruses with radiolabeled antibodies

Arturo Casadevall, Harris Goldstein, Ekaterina Dadachova

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Existing antiviral therapies produce a therapeutic effect by suppressing viral replication and reducing viral burden and the associated inflammatory reaction. However, infection with many viruses results in chronic infections that cannot be eradicated by the immune response or available antiviral drugs. As viruses are obligate intracellular pathogens, it should be possible to eradicate chronic infections by targeting and eliminating the infected host cells. Radioisotope-conjugated antibodies that specifically bind viral antigens can deliver cytotoxic radiation to virally infected cells. This approach was recently shown to target and eliminate HIV-1-infected cells in vitro and in mouse models, and provides a new approach for eliminating virally infected cells.

Original languageEnglish (US)
Pages (from-to)595-597
Number of pages3
JournalExpert Opinion on Biological Therapy
Volume7
Issue number5
DOIs
StatePublished - May 2007

Fingerprint

Viruses
Antiviral Agents
Viral Antigens
Antibodies
Pathogens
Radioisotopes
Infection
Radiation
Therapeutic Uses
Viral Load
HIV-1
Therapeutics

Keywords

  • HIV
  • Immunoglobulins
  • Radiation
  • Radioimmunotherapy
  • Viruses

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics
  • Immunology

Cite this

Targeting host cells harbouring viruses with radiolabeled antibodies. / Casadevall, Arturo; Goldstein, Harris; Dadachova, Ekaterina.

In: Expert Opinion on Biological Therapy, Vol. 7, No. 5, 05.2007, p. 595-597.

Research output: Contribution to journalArticle

Casadevall, Arturo ; Goldstein, Harris ; Dadachova, Ekaterina. / Targeting host cells harbouring viruses with radiolabeled antibodies. In: Expert Opinion on Biological Therapy. 2007 ; Vol. 7, No. 5. pp. 595-597.
@article{07a93c634f9042a496e429c5d700e306,
title = "Targeting host cells harbouring viruses with radiolabeled antibodies",
abstract = "Existing antiviral therapies produce a therapeutic effect by suppressing viral replication and reducing viral burden and the associated inflammatory reaction. However, infection with many viruses results in chronic infections that cannot be eradicated by the immune response or available antiviral drugs. As viruses are obligate intracellular pathogens, it should be possible to eradicate chronic infections by targeting and eliminating the infected host cells. Radioisotope-conjugated antibodies that specifically bind viral antigens can deliver cytotoxic radiation to virally infected cells. This approach was recently shown to target and eliminate HIV-1-infected cells in vitro and in mouse models, and provides a new approach for eliminating virally infected cells.",
keywords = "HIV, Immunoglobulins, Radiation, Radioimmunotherapy, Viruses",
author = "Arturo Casadevall and Harris Goldstein and Ekaterina Dadachova",
year = "2007",
month = "5",
doi = "10.1517/14712598.7.5.595",
language = "English (US)",
volume = "7",
pages = "595--597",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Targeting host cells harbouring viruses with radiolabeled antibodies

AU - Casadevall, Arturo

AU - Goldstein, Harris

AU - Dadachova, Ekaterina

PY - 2007/5

Y1 - 2007/5

N2 - Existing antiviral therapies produce a therapeutic effect by suppressing viral replication and reducing viral burden and the associated inflammatory reaction. However, infection with many viruses results in chronic infections that cannot be eradicated by the immune response or available antiviral drugs. As viruses are obligate intracellular pathogens, it should be possible to eradicate chronic infections by targeting and eliminating the infected host cells. Radioisotope-conjugated antibodies that specifically bind viral antigens can deliver cytotoxic radiation to virally infected cells. This approach was recently shown to target and eliminate HIV-1-infected cells in vitro and in mouse models, and provides a new approach for eliminating virally infected cells.

AB - Existing antiviral therapies produce a therapeutic effect by suppressing viral replication and reducing viral burden and the associated inflammatory reaction. However, infection with many viruses results in chronic infections that cannot be eradicated by the immune response or available antiviral drugs. As viruses are obligate intracellular pathogens, it should be possible to eradicate chronic infections by targeting and eliminating the infected host cells. Radioisotope-conjugated antibodies that specifically bind viral antigens can deliver cytotoxic radiation to virally infected cells. This approach was recently shown to target and eliminate HIV-1-infected cells in vitro and in mouse models, and provides a new approach for eliminating virally infected cells.

KW - HIV

KW - Immunoglobulins

KW - Radiation

KW - Radioimmunotherapy

KW - Viruses

UR - http://www.scopus.com/inward/record.url?scp=34248223714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248223714&partnerID=8YFLogxK

U2 - 10.1517/14712598.7.5.595

DO - 10.1517/14712598.7.5.595

M3 - Article

VL - 7

SP - 595

EP - 597

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 5

ER -